Skip to main content
. 2020 Nov 27;20:1095. doi: 10.1186/s12913-020-05952-6

Table 4.

Consumption of diabetes medications in 2016 and 2017.

N of users (N of purchases) Total consumption, DDDs Purchases/patient (SD) DDDs/patient/purchase (SD) DDDs/patient/year (SD)
2016 2017 2016 2017 2016 2017 P value 2016 2017 P value 2016 2017 P value
All patients (n = 8143) 7116 (55,104) 7036 (58,212) 12,065 11,621 7.7 (7.5) 8.3 (8.2) < 0.001 79.9 (61.3) 72.9 (59.4) < 0.001 618.9 (487.8) 602.9 (475.6) 0.048
Patients alive on Jan 1, 2018 (n = 8025) 6793 (52,050) 6780 (56,764) 11,619 11,446 7.7 (7.4) 8.4 (8.2) < 0.001 81.5 (60.9) 73.6 (59.3) < 0.001 624.3 (489.0) 616.2 (477.2) 0.326
Subgroup analyses:
 Used only metformin in 2016 (n = 2271) 2271 (9632) 2184 (10,036) 1678 1681 4.2 (4.2) 4.6 (4.6) 0.007 63.6 (42.6) 61.1 (42.2) < 0.001 269.6 (129.0) 280.9 (145.4) 0.006
 Used metformin and other OAD in 2016 (n = 1430) 1430 (12,946) 1412 (14,009) 2806 2700 9.1 (7.7) 9.9 (8.7) 0.005 79.1 (44.0) 70.3 (44.9) < 0.001 716.3 (268.6) 697.9 (299.2) 0.084
 Used only other diabetes medications than insulin or metformin in 2016 (n = 726) 726 (4009) 694 (4316) 714 701 5.5 (5.3) 6.2 (5.6) 0.016 65.0 (41.9) 59.3 (39.7) < 0.001 358.8 (169.4) 368.6 (193.9) 0.309
 Used insulin and OAD (incl. metformin) in 2016 (n = 2112) 2112 (25,656) 2088 (26,503) 6046 5745 12.1 (9.0) 12.7 (9.8) 0.061 86.0 (72.3) 79.2 (70.7) < 0.001 1044.9 (572.1) 1004.9 (559.7) 0.022
 Used only insulin in 2016 (n = 577) 577 (2861) 548 (2893) 821 737 5.0 (2.5) 5.3 (3.2) 0.064 104.8 (77.0) 93.0 (70.4) < 0.001 519.6 (440.6) 490.8 (413.1) 0.259
 Patients alive on Oct 1, 2019 (n = 7669) 6730 (51,486) 6721 (56,235) 11,526 11,372 7.7 (7.3) 8.4 (8.2) < 0.001 81.7 (60.7) 73.8 (59.3) < 0.001 625.1 (488.6) 617.6 (477.9) 0.366

Abbreviations: DDD defined daily dose, OAD oral antidiabetic drug